IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Ally Bridge Group (NY) LLC

Q1 2023 Holdings

Filed 2023-05-15 | 18 holdings | $76.3M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Verona Pharma PLC(VRNA)SPONSORED ADS925050106$9.8M487,63112.8%
Xenon Pharmaceuticals Inc(XENE)COM98420N105$9.6M266,96112.5%
Bellus Health Inc New(BLU)COM NEW07987C204$8.1M1,131,82710.7%
Cytokinetics Inc(CYTK)COM NEW23282W605$7.9M223,38210.3%
Madrigal Pharmaceuticals Inc(MDGL)COM558868105$7.2M29,6149.4%
Iveric BIO Inc(OPHTEUR)COM46583P102$6.2M255,3108.1%
Merus NVCOMN5749R100$5.1M275,9706.7%
Mersana Therapeutics IncCOM59045L106$4.9M1,191,2716.4%
Jasper Therapeutics IncCOM471871103$4.6M2,517,2326.0%
Sarepta Therapeutics Inc(SRPT)COM803607100$2.9M20,8303.8%
CTI Biopharma Corp(CTIC1USD)COM12648L601$2.3M550,0003.0%
Medavail Holdings IncCOM58406B103$1.7M5,894,8972.2%
Mdxhealth SASPONSORED ADS58286E102$1.6M500,0002.1%
Moonlake Immunotherapeutics(MLTX)CLASS A ORD61559X104$1.6M72,8502.0%
Rapid Micro Biosystems Inc(RPID)CLASS A COM75340L104$916.6K699,6641.2%
Essa Pharma Inc(EPIEUR)COM NEW29668H708$702.7K236,5830.9%
Kinnate Biopharma IncCOM49705R105$683.7K109,3930.9%
Syros Pharmaceuticals Inc(SYRS)COM NEW87184Q206$665.2K249,1260.9%